Sheba Medical Center: COVID-19 trials
The registry lists 10 COVID-19 studies with Sheba Medical Center as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 1Phase 3 1Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Enhanced External Counterpulsation to Treat Long COVID-19 FatigueRecruitingNCT05668039Not applicable
- Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in AdultsCompletedNCT05383560Phase 2
- Fourth BNT162b2 COVID-19 Vaccine DoseActive, not recruitingNCT05231005Phase 4
- Fourth COVID-19 Vaccine Dose- mRNA1273Active, not recruitingNCT05230953Phase 3
- Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and AlemtuzumabStatus unknownNCT05075499Not applicable
- Semen Analysis Parameters Following Pfizer's COVID-19 VaccineStatus unknownNCT04778033
- Synthetic CBD as a Therapy for COVID-19Status unknownNCT04686539Phase 1
- Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19Status unknownNCT04438863
- Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19Status unknownNCT04429711Not applicable
- The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical PatientsStatus unknownNCT04338672